Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medical Futures introduces purfem probiotic in Canada
Purfem probiotic is a natural health product for the prevention and treatment of vaginal itching, burning, dryness, odour and/or slightly increased discharge caused by an imbalance of the
Purfem probiotic is a natural health product for the prevention and treatment of vaginal itching, burning, dryness, odour and/or slightly increased discharge caused by an imbalance of the
Provectus said that the protocol for the compassionate use program enables subjects to undergo more frequent and extensive treatments of PV-10 over a longer period of time than
Merrion claimed that the agreement will evaluate the ability of its patented Gipet technology to enhance the compounds’ clinical profile and provide a substantially improved product. On successful
The purchase price includes $7.8m of cash and the remaining $3m will be paid in 379,039 shares of Omeros common stock. Omeros has no milestone, royalty or other
CNS claims that Gablofen is compatible with Medtronic’s SynchroMedII programmable drug pumps and is offered in the same standard concentrations as Lioresal intrathecal (baclofen injection), a drug manufactured
Standard Process claimed that Calamari Omega-3 Liquid is a convenient way to increase omega-3 essential fatty acid intake for both general and targeted system support, and in addition
Idenix said that, in February 2009, it licensed to GlaxoSmithKline (GSK) on a worldwide basis, a non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidate, ‘761, for the treatment of
The grant of $194,000 was awarded under the Foundation’s Therapeutics Development Initiative Fall 2010 Program. MJFF Research Partnerships vice president Sohini Chowdhury said that levodopa-induced dyskinesia is a
As per the terms of the agreement, GSK will transfer ownership of its penicillin manufacturing site in Bristol, Tennessee, US, and rights for the Augmentin and Amoxil brands
Gilead said that if approved, this would be the second product that contains a complete HIV treatment regimen in a single once-daily tablet. Gilead entered into a license